PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
PHAS
Delisted
PHAS was delisted on the 2nd of November, 2022.
50 hedge funds and large institutions have $60M invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 12 closing their positions.
Holders
50
Holders Change
-10
Holders Change %
-16.67%
% of All Funds
1.01%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
18
Reduced
15
Closed
12
Calls
$61K
Puts
–
Net Calls
+$61K
Net Calls Change
+$51K